[OPINION] From Dengvaxia to Daraxonrasib: Can the Philippines restore trust in medical innovation?
Findings about a novel targeted therapy for pancreatic cancer represent genuine hope. However, it may take time for Filipinos to trust it after its trauma from the Dengvaxia controversy.
Original Source
Read the full article at Rappler →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.